Hint mode is switched on Switch off

Day One Biopharmaceuticals, ordinary share
DAWN, US23954D1090

Add a stock to WL
Choose all Reset all
Day One Biopharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Day One Biopharmaceuticals, Inc. operates as a biotechnology company. The Company focuses on science research, technologies, therapeutic development, and makes medicines for the treatment and diagnosis of cancer. Day One Biopharmaceuticals serves patients, healthcare professionals, pharmaceutical, ...
Day One Biopharmaceuticals, Inc. operates as a biotechnology company. The Company focuses on science research, technologies, therapeutic development, and makes medicines for the treatment and diagnosis of cancer. Day One Biopharmaceuticals serves patients, healthcare professionals, pharmaceutical, and biotechnology industries in the United States.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Day One Biopharmaceuticals, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    DAWN
  • Placement
    27.05.2021
  • Lock up period
    180
  • Number of papers
    10,000,000
  • Volume of raised funds
    160 mln USD
  • Placement share
    16.55%
  • Final placement price
    16 USD
  • Price change since placement date
    34.56%
  • By capitalization
    966.86 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    DAWN
  • Placement
    16.06.2022
  • Lock up period
    180
  • Number of papers
    10,000,000
  • Volume of raised funds
    150 mln USD
  • Placement share
    13.91%
  • Final placement price
    15 USD
  • Price change since placement date
    43.53%
  • By capitalization
    1,078.68 mln USD

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
II q eng
III q eng
IV q eng
Show all Hide

Indicators

News

22/04/2026 Day One Biopharmaceuticals: Termination Of A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, , Item 5.01 And Item 5.03 Are Incorporated Herein By Reference, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
06/03/2026 Day One Biopharmaceuticals: Entry Into A Material Definitive Agreement, Other Events, Financial Statements And Exhibits
02/03/2026 Day One Biopharmaceuticals: Regulation Fd Disclosure, Financial Statements And Exhibits
06/01/2026 Day One Biopharmaceuticals: Of The Original Report To Include The Audited Consolidated Financial Statements Of Target (as Defined In The Original Report) As Of And For The Years Ended December 31, 2024 And December 31, 2023 And To Include The Unaudited Interim Condensed Consolidated Financial Statements Of Target As Of And For The Three And Nine Months Ended September 30, 2025; And (ii) Update The Information In Item 9.01(b) Of The Original Report To Include The Unaudited Pro Forma Condensed Combined Financial Information Of Parent And Target (collectively, The "
06/01/2026 Day One Biopharmaceuticals: Entry Into A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Regulation Fd Disclosure, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.